BAL PHARMA
Back to Income Statement
|
BAL PHARMA Last 5 Year Operating Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Operating Profit (Excl OI) | ₹32 Cr | ₹25 Cr | ₹24 Cr | ₹25 Cr | ₹5.03 Cr |
What is the latest Operating Profit of BAL PHARMA ?
Year | Operating Profit |
---|---|
Mar2024 | ₹32 Cr |
Mar2023 | ₹25 Cr |
Mar2022 | ₹24 Cr |
Mar2021 | ₹25 Cr |
Mar2020 | ₹5.03 Cr |
How is Operating Profit of BAL PHARMA Trending?
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹32 Cr | 25.59 | |
Mar2023 | ₹25 Cr | 5.30 | |
Mar2022 | ₹24 Cr | -2.70 | |
Mar2021 | ₹25 Cr | 390.23 | |
Mar2020 | ₹5.03 Cr | - |
Compare Operating Profit of peers of BAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAL PHARMA | ₹217.6 Cr | 20% | 6.9% | 16.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹426,518.0 Cr | -0.1% | -6.3% | 49.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,636.0 Cr | 3.5% | 0.9% | 66.2% | Stock Analytics | |
CIPLA | ₹118,368.0 Cr | -2.6% | -3.8% | 19.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,671.4 Cr | -4.1% | -10.8% | 9.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,013.6 Cr | -2% | -6.1% | 49.9% | Stock Analytics |
BAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAL PHARMA | 20% |
6.9% |
16.6% |
SENSEX | -1.9% |
-5% |
17.5% |
You may also like the below Video Courses